Cargando…
Combination of Gemcitabine with Cell-Penetrating Peptides: A Pharmacokinetic Approach Using in Silico Tools
Gemcitabine is an anticancer drug used to treat a wide range of solid tumors and is a first line treatment for pancreatic cancer. Our group has previously developed novel conjugates of gemcitabine with cell-penetrating peptides (CPP), and here we report some preliminary data regarding the pharmacoki...
Autores principales: | Ferreira, Abigail, Lapa, Rui, Vale, Nuno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921036/ https://www.ncbi.nlm.nih.gov/pubmed/31690028 http://dx.doi.org/10.3390/biom9110693 |
Ejemplares similares
-
Permeability of Gemcitabine and PBPK Modeling to Assess Oral Administration
por: Ferreira, Abigail, et al.
Publicado: (2021) -
Permeability evaluation of gemcitabine-CPP6 conjugates in Caco-2 cells
por: Ferreira, Abigail, et al.
Publicado: (2020) -
New In Vitro-In Silico Approach for the Prediction of In Vivo Performance of Drug Combinations
por: Correia, Cristiana, et al.
Publicado: (2021) -
Combination of Cell-Penetrating Peptides with Nanoparticles for Therapeutic Application: A Review
por: Silva, Sara, et al.
Publicado: (2019) -
In silico approaches for designing highly effective cell penetrating peptides
por: Gautam, Ankur, et al.
Publicado: (2013)